IL1B and breast cancer: Our previous work, utilizing an in vitro model of non-invasive epithelial human breast cancer cells (MCF-7), demonstrated that treatment with the inflammatory cytokine IL-1β transforms these cells to malignancy (thereafter, 6D cells), through an epithelial–mesenchymal transition (EMT) process [3,4].